D
Teva Pharmaceutical Industries Limited TEVA
$16.33 -$0.13-0.79%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -192.68% 58.96% 80.72% 71.99% 77.10%
Total Depreciation and Amortization -8.15% -11.48% -12.27% -13.03% -11.85%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 167.06% -28.49% -60.84% -34.17% -38.31%
Change in Net Operating Assets -504.17% 737.50% -245.39% -149.33% -105.32%
Cash from Operations -8.85% 60.41% -31.09% -7.03% -13.96%
Capital Expenditure 5.32% 11.11% 6.32% 3.58% 4.01%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -36.76% -57.14% -86.75% 46.67% 0.00%
Other Investing Activities -11.50% 4.80% 5.09% 19.91% 24.87%
Cash from Investing -18.18% 6.71% 1.13% 37.93% 47.79%
Total Debt Issued -- -100.00% -71.44% -71.44% --
Total Debt Repaid 66.18% 71.23% 37.14% 62.40% -254.42%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 29.25% -70.50% -128.47% -188.71% -81.20%
Cash from Financing 6.38% 17.33% -18.73% 38.10% -28.73%
Foreign Exchange rate Adjustments -480.00% -68.75% -3,833.33% -197.96% 75.61%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -81.42% 13,462.50% -171.16% 1,201.35% -38.21%
Weiss Ratings